Taiwan expands eligibility for using Moderna's COVID-19 vaccine as booster for children

The Central Epidemic Command Center (CECC) in Taiwan has reported that the Advisory Committee on Immunisation Practices (ACIP) at the Ministry of Health and Welfare recently held an expert meeting and issued its recommendations on the use of Moderna's BA.4/BA.5 bivalent COVID-19 vaccine as a booster for children. 

Moderna's BA.4/BA.5 bivalent COVID-19 vaccine can be given as a booster to children 6 months through 5 years of age who have completed their primary series vaccination.

The bivalent COVID-19 vaccine is not suitable for use in children 6 months through 5 years of age who have completed their primary series vaccination with the Pfizer-BioNTech vaccine for children. These children are recommended to follow the current recommendations to receive three primary series doses of the Pfizer-BioNTech vaccine for children.